EFNB2 and neoplasm: Expression of truncated, soluble EphB4 receptor in breast cancer cells in a mouse xenograft model (with ephrinB2 ligand primarily expressed in the vasculature) increased tumor angiogenesis, suggesting that soluble EphB4 promotes tumor growth by stimulating angiogenesis through ephrinB2 signaling [101].